| SC 13G/A | 2016-02-16 | Cormorant Global Healthcare Master Fund, LP | Recro Pharma, Inc. | 780,000 | - | EDGAR |
| SC 13G/A | 2016-01-11 | SABBY MANAGEMENT, LLC | Recro Pharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2015-07-17 | Tourbillon Capital Partners LP | Recro Pharma, Inc. | 646,552 | 7.0% | EDGAR |
| SC 13D | 2015-07-15 | Broadfin Capital, LLC | Recro Pharma, Inc. | 2,060,086 | 22.3% | EDGAR |
| SC 13G/A | 2015-02-23 | Avet Capital Management, LLC | Recro Pharma, Inc. | 31,765 | 0.4% | EDGAR |
| SC 13G/A | 2015-02-17 | Broadfin Capital, LLC | Recro Pharma, Inc. | 1,413,533 | 18.3% | EDGAR |
| SC 13G/A | 2015-02-17 | Cormorant Global Healthcare Master Fund, LP | Recro Pharma, Inc. | 700,000 | - | EDGAR |
| SC 13G/A | 2015-02-17 | GREAT POINT PARTNERS LLC | Recro Pharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2015-02-13 | Opaleye Management Inc. | Recro Pharma, Inc. | - | - | EDGAR |
| SC 13G/A | 2015-01-12 | SABBY MANAGEMENT, LLC | Recro Pharma, Inc. | 707,836 | 9.2% | EDGAR |
| SC 13G | 2014-09-15 | Broadfin Capital, LLC | Recro Pharma, Inc. | 1,172,195 | 15.2% | EDGAR |
| SC 13G | 2014-09-04 | Avet Capital Management, LLC | Recro Pharma, Inc. | 387,100 | 5.0% | EDGAR |
| SC 13G | 2014-07-24 | Opaleye Management Inc. | Recro Pharma, Inc. | - | - | EDGAR |
| SC 13D | 2014-03-21 | SCP Vitalife Partners II LP | Recro Pharma, Inc. | 2,374,046 | - | EDGAR |
| SC 13G | 2014-03-18 | GREAT POINT PARTNERS LLC | Recro Pharma, Inc. | 580,000 | 8.1% | EDGAR |
| SC 13G | 2014-03-17 | Cormorant Asset Management, LLC | Recro Pharma, Inc. | 500,000 | - | EDGAR |
| SC 13G | 2014-03-14 | SABBY MANAGEMENT, LLC | Recro Pharma, Inc. | 437,500 | 6.0% | EDGAR |
| SC 13G | 2014-03-13 | Broadfin Capital, LLC | Recro Pharma, Inc. | 580,000 | 8.1% | EDGAR |